Rate Article: Successful High-Titer Immunoglobulin Therapy for Persistent Parvovirus B19 Infection in a Lymphoma Patient Treated with Rituximab-Combined Chemotherapy
International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064


Rate this Article: Successful High-Titer Immunoglobulin Therapy for Persistent Parvovirus B19 Infection in a Lymphoma Patient Treated with Rituximab-Combined Chemotherapy

1
Please enter 100–200 characters. 0/200 characters

Back to Article




Top

Confirm Your Share

Enter your details so IJSR can confirm this sharing activity.

Your details are used to validate this share and protect the award process from duplicate or false activity.